• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氨基糖苷类药物致聋中线粒体小核糖体RNA基因的易感性突变

Susceptibility mutations in the mitochondrial small ribosomal RNA gene in aminoglycoside induced deafness.

作者信息

Bacino C, Prezant T R, Bu X, Fournier P, Fischel-Ghodsian N

机构信息

Ahmanson Department of Pediatrics, Steven Spielberg Pediatric Research Center, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.

出版信息

Pharmacogenetics. 1995 Jun;5(3):165-72. doi: 10.1097/00008571-199506000-00005.

DOI:10.1097/00008571-199506000-00005
PMID:7550368
Abstract

Aminoglycoside induced deafness has been linked recently to a predisposing homoplasmic mutation in the 3' end of the small ribosomal RNA (rRNA) gene of the human mitochondria (1555 A-->G) that makes the mitochondrial rRNA structurally more similar to its bacterial counterpart. This mitochondrial DNA mutation was consistently found in families in which the susceptibility to develop ototoxic deafness was inherited through the maternal lineage. However, the 1555 A-->G mutation was rarely found in sporadic patients in China, where a significant proportion of the population has been exposed to aminoglycosides. To further characterize the mutations predisposing to aminoglycoside ototoxicity, we analysed the 12S rRNA gene in 35 Chinese sporadic patients without the 1555 A-->G mutation. Using single stranded conformational polymorphism (SSCP) analysis, heteroduplex (HD) analysis, sequencing, and allele specific oligonucleotide hybridization, we found three out of 35 sporadic patients with unique sequence changes in the 12S rRNA gene. Two of the patients had homoplasmic mutations. One patient displayed localized heteroplasmy around nt 961, with an absence of the thymidine at this position and different populations of mitochondrial DNA with varying numbers of inserted cytosines. The description of these putative susceptibility mutations, in particular the heteroplasmic mutation around nt 961, provides further support for the important role of the mitochondrial 12S rRNA in genetic predisposition to aminoglycoside induced ototoxic deafness.

摘要

氨基糖苷类抗生素所致耳聋最近被认为与人类线粒体小核糖体RNA(rRNA)基因3'端的一种易感性纯质突变(1555 A→G)有关,该突变使线粒体rRNA在结构上与其细菌对应物更相似。这种线粒体DNA突变在通过母系遗传对耳毒性耳聋易感性的家族中一直被发现。然而,在中国散发性患者中很少发现1555 A→G突变,而该国相当一部分人口曾接触过氨基糖苷类抗生素。为了进一步确定导致氨基糖苷类耳毒性的突变特征,我们分析了35例无1555 A→G突变的中国散发性患者的12S rRNA基因。通过单链构象多态性(SSCP)分析、异源双链(HD)分析、测序和等位基因特异性寡核苷酸杂交,我们在35例散发性患者中发现3例12S rRNA基因有独特的序列变化。其中2例患者有纯质突变。1例患者在nt961附近表现出局部异质性,该位置缺乏胸腺嘧啶,并且存在不同数量插入胞嘧啶的线粒体DNA群体。这些假定的易感性突变的描述,特别是nt961附近的异质性突变,为线粒体12S rRNA在氨基糖苷类抗生素所致耳毒性耳聋遗传易感性中的重要作用提供了进一步的支持。

相似文献

1
Susceptibility mutations in the mitochondrial small ribosomal RNA gene in aminoglycoside induced deafness.氨基糖苷类药物致聋中线粒体小核糖体RNA基因的易感性突变
Pharmacogenetics. 1995 Jun;5(3):165-72. doi: 10.1097/00008571-199506000-00005.
2
Mitochondrial ribosomal RNA gene mutation in a patient with sporadic aminoglycoside ototoxicity.一名散发性氨基糖苷类耳毒性患者的线粒体核糖体RNA基因突变
Am J Otolaryngol. 1993 Nov-Dec;14(6):399-403. doi: 10.1016/0196-0709(93)90113-l.
3
Inherited susceptibility to aminoglycoside ototoxicity: genetic heterogeneity and clinical implications.氨基糖苷类药物耳毒性的遗传易感性:遗传异质性及临床意义。
Am J Otolaryngol. 1999 May-Jun;20(3):151-6. doi: 10.1016/s0196-0709(99)90062-5.
4
Mitochondrial tRNAThr G15927A mutation may modulate the phenotypic manifestation of ototoxic 12S rRNA A1555G mutation in four Chinese families.线粒体tRNA苏氨酸基因G15927A突变可能调节四个中国家系中致耳毒性的12S rRNA A1555G突变的表型表现。
Pharmacogenet Genomics. 2008 Dec;18(12):1059-70. doi: 10.1097/FPC.0b013e3283131661.
5
Mutation in the mitochondrial 12S rRNA gene in two families from Mongolia with matrilineal aminoglycoside ototoxicity.来自蒙古的两个母系遗传氨基糖苷类耳毒性家族的线粒体12S rRNA基因突变。
J Med Genet. 1997 Feb;34(2):169-72. doi: 10.1136/jmg.34.2.169.
6
Mitochondrial haplotypes may modulate the phenotypic manifestation of the deafness-associated 12S rRNA 1555A>G mutation.线粒体单倍型可能调节与耳聋相关的 12S rRNA 1555A>G 突变的表型表现。
Mitochondrion. 2010 Jan;10(1):69-81. doi: 10.1016/j.mito.2009.09.007. Epub 2009 Oct 8.
7
Specific binding of aminoglycosides to a human rRNA construct based on a DNA polymorphism which causes aminoglycoside-induced deafness.基于导致氨基糖苷类药物致聋的DNA多态性的人rRNA构建体与氨基糖苷类药物的特异性结合。
Biochemistry. 1997 Oct 7;36(40):12323-8. doi: 10.1021/bi970962r.
8
Mitochondrial ribosomal RNA mutation associated with both antibiotic-induced and non-syndromic deafness.与抗生素诱导性和非综合征性耳聋相关的线粒体核糖体RNA突变
Nat Genet. 1993 Jul;4(3):289-94. doi: 10.1038/ng0793-289.
9
Two large Spanish pedigrees with nonsyndromic sensorineural deafness and the mtDNA mutation at nt 1555 in the 12s rRNA gene: evidence of heteroplasmy.两个患有非综合征性感音神经性耳聋且12s rRNA基因nt 1555位点存在线粒体DNA突变的西班牙大家族系:异质性证据
Neurology. 1997 Feb;48(2):453-6. doi: 10.1212/wnl.48.2.453.
10
Genetic analysis of interactions with eukaryotic rRNA identify the mitoribosome as target in aminoglycoside ototoxicity.与真核生物核糖体RNA相互作用的遗传分析确定线粒体核糖体是氨基糖苷类耳毒性的靶点。
Proc Natl Acad Sci U S A. 2008 Dec 30;105(52):20888-93. doi: 10.1073/pnas.0811258106. Epub 2008 Dec 22.

引用本文的文献

1
Sensorineural Hearing Loss in Patients With the m.1555A>G Mutation in the MTRNR1 Gene.患有线粒体核糖体RNA 1(MTRNR1)基因m.1555A>G突变患者的感音神经性听力损失
Laryngoscope. 2025 Feb;135(2):901-907. doi: 10.1002/lary.31796. Epub 2024 Sep 26.
2
Human Mitoribosome Biogenesis and Its Emerging Links to Disease.人类线粒体核糖体的生物发生及其与疾病的新联系。
Int J Mol Sci. 2021 Apr 7;22(8):3827. doi: 10.3390/ijms22083827.
3
Blackout in the powerhouse: clinical phenotypes associated with defects in the assembly of OXPHOS complexes and the mitoribosome.
动力车间停电:与 OXPHOS 复合物和线粒体核糖体组装缺陷相关的临床表型。
Biochem J. 2020 Nov 13;477(21):4085-4132. doi: 10.1042/BCJ20190767.
4
A Novel Approach for the Identification of Pharmacogenetic Variants in through Next-Generation Sequencing Off-Target Data.一种通过下一代测序脱靶数据鉴定药物遗传学变异的新方法。
J Clin Med. 2020 Jul 2;9(7):2082. doi: 10.3390/jcm9072082.
5
Mitochondrial DNA mutations associated with aminoglycoside induced ototoxicity.与氨基糖苷类药物所致耳毒性相关的线粒体DNA突变
J Otol. 2017 Mar;12(1):1-8. doi: 10.1016/j.joto.2017.02.001. Epub 2017 Feb 11.
6
PharmGKB summary: very important pharmacogene information for MT-RNR1.药物基因组知识库总结:MT-RNR1的非常重要的药物基因信息。
Pharmacogenet Genomics. 2016 Dec;26(12):558-567. doi: 10.1097/FPC.0000000000000247.
7
Association of TMTC2 With Human Nonsyndromic Sensorineural Hearing Loss.TMTC2与人类非综合征性感音神经性听力损失的关联。
JAMA Otolaryngol Head Neck Surg. 2016 Sep 1;142(9):866-72. doi: 10.1001/jamaoto.2016.1444.
8
Association between idiopathic hearing loss and mitochondrial DNA mutations: a study on 169 hearing-impaired subjects.特发性听力损失与线粒体 DNA 突变的相关性:对 169 名听力受损患者的研究。
Int J Mol Med. 2013 Oct;32(4):785-94. doi: 10.3892/ijmm.2013.1470. Epub 2013 Aug 16.
9
Genetic mutations of GJB2 and mitochondrial 12S rRNA in nonsyndromic hearing loss in Jiangsu Province of China.中国江苏地区非综合征型听力损失与 GJB2 和线粒体 12S rRNA 基因突变的关系。
J Transl Med. 2013 Jul 4;11:163. doi: 10.1186/1479-5876-11-163.
10
mtDNA mutations, hearing loss and aminoglycoside treatment in Mexicans.墨西哥人的 mtDNA 突变、听力损失和氨基糖苷类药物治疗。
Braz J Otorhinolaryngol. 2011 Sep-Oct;77(5):573-6. doi: 10.1590/s1808-86942011000500006.